Application of the consistency approach to reduce animal use in vaccine potency testing

Procedia in Vaccinology

Volumn 5, Issue , 2011, Pages 232-235

  Kulpa Eddy, Jodie ^a   Dusek, David ^a  

^a UNITED STATES DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

Alternatives; Consistency approach; Vaccine potency test

Indexed keywords

VACCINE;

ANALYTIC METHOD; ARTICLE; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; HUMAN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; WORKSHOP;

EID: 84555190317     PISSN: None     EISSN: 1877282X     Source Type: Journal    
DOI: 10.1016/j.provac.2011.10.024     Document Type: Article

References (17)

1. Quoted in Monke J. The Virus-Serum-Toxin Act: A Brief History and Analysis. CRC Report for Congress. Washington, DC: Congressional Research Service, 2005. Available at: http://www.nationalaglawcenter.org/assets/crs/RS22014.pdf.
2. U.S. Biologics Control Act of 1902.
3. ANON (1960). The Pharmaceutical Affairs Law. Japan Law No. 145 in 1960, as amended on 26 June 1996. Pharmaceutical Affairs Law, Enforcement Ordinance and Enforcement Regulations, Yakugyo Jiho, Japan, 2-91 (in Japanese and English).
4. Directive 2001/82/EC of The European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products. Official Journal of the European Communities, 2001.
5. Directive, 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. Official Journal of the European Communities, 2001.
6. European Pharmacopoeia, 7th edition. Strasbourg: Directorate for the Quality of Medicines & HealthCare of the Council of Europe (EDQM), 2011.
7. U.S. Code of Federal Regulations. 9 CFR 113.113. Title 9-Animals and Animal Products; Chapter 1-Animal and Plant Health Inspection Service, Department of Agriculture; Subchapter E-Viruses, Serums, Toxins, and Analogous Products: Organisms and Vectors; Part 113-Standard Requirements; Section 113.113-Autogenous biologics. Available at: http://edocket.access.gpo.gov/cfr_2009/janqtr/pdf/9cfr113.113.pdf.
8. U.S. Code of Federal Regulations. 9 CFR 101. Title 9-Animals and Animal Products; Chapter 1-Animal and Plant Health Inspection Service, Department of Agriculture; Subchapter E-Viruses, Serums, Toxins, and Analogous Products: Organisms and Vectors; Part 101-Definitions. Available at: http://www.access.gpo.gov/nara/cfr/waisidx_09/9cfr101_09.html.
9. Espeseth DA. Licensing veterinary biologics in the United States. Dev Biol Stand 1992;79:17-25. Available at: http://www.ncbi.nlm.nih.gov/pubmed/1286752.
10. Hendriksen C, Arciniega JL, Bruckner L, Chevalier M, Coppens E, Descamps J, Duchêne M, Dusek DM, Halder M, Kreeftenberg H, Maes A, Redhead K, Ravetkar SD, Speiser JM, Swam H. The consistency approach for the quality control of vaccines. Biologicals 2008;36(1):73-7. Available at: http://ddr.nal.usda.gov/bitstream/10113/10964/1/IND44023879.pdf.
11. Metz B, Hendriksen CF, Jiskoot W, Kersten GF. Reduction of animal use in human vaccine quality control: opportunities and problems. Vaccine 2002;20:2411-30. Available at: http://igitur-archive.library.uu.nl/dissertations/2005-0303-105230/c2.pdf.
12. De Mattia F., Chapsal J.M., Descamps J., Halder M., Jarrett N., Kross I., Mortiaux F., Ponsar C., Redhead K., McKelvie J., Hendriksen C. The consistency approach for quality control of vaccines - a strategy to improve quality control and implement 3Rs. Biologicals 2011, 39:59-65.
13. Hendriksen, C. Three Rs achievements in vaccinology. In: Proceedings of the 6th World Congress on Alternatives & Animal Use in the Life Sciences. 21-25 August 2007. Tokyo, Japan. AATEX 2008; 14 (Special Issue): 575-9. Available at: http://altweb.jhsph.edu/bin/q/t/paper575.pdf.
14. U.S. Code of Federal Regulations. 9 CFR 113.8. Title 9-Animals and Animal Products; Chapter I-Animal and Plant Health Inspection Service, Department of Agriculture; Subchapter E-Viruses, Serums, Toxins, and Analogous Products: Organisms and Vectors; Part 113-Standard Requirements; Section 113.8-In vitro tests for serial release. Available at: http://edocket.access.gpo.gov/cfr_2009/janqtr/pdf/9cfr113.8.pdf.
15. European Pharmacopoeia. Monograph 0153. Vaccines for human use. 7th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe; 2010.
16. European Pharmacopoeia. Monograph 0062. Vaccines for veterinary use. 7th ed. Strasbourg, France: European Department for the Quality of Medicines within the Council of Europe; 2010.
17. Hendriksen, C. Refinement, reduction, and replacement of animal use for regulatory testing: current best scientific practices for the evaluation of safety and potency of biologicals. ILAR J 2002; 43(Suppl):S43-8. Available at: http://dels-old.nas.edu/ilar_n/ilarjournal/43_supp/v43supHendriksen.pdf.